Innoviva, Inc.
INVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080014
No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Innoviva, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 285
- +12 vs. Q4 2025
- Shares held
- 75.5M
- +8.35M (+12.4%) vs. Q4 2025
- Total value
- $1.76B
- +$417.0M (+31.1%) vs. Q4 2025
- New holders
- 48
- 116 more added
- Sold out
- 36
- 87 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 308 | $1.69B |
| Q1 2026 | 285 | $1.76B |
| Q4 2025 | 280 | $1.50B |
| Q3 2025 | 263 | $1.38B |
| Q2 2025 | 266 | $1.47B |
| Q1 2025 | 247 | $1.24B |
| Q4 2024 | 236 | $1.24B |
| Q3 2024 | 221 | $1.41B |
| Q2 2024 | 213 | $1.20B |
| Q1 2024 | 216 | $1.11B |
| Q4 2023 | 197 | $1.16B |
| Q3 2023 | 193 | $892.4M |
| Q2 2023 | 198 | $898.1M |
| Q1 2023 | 193 | $789.0M |
| Q4 2022 | 208 | $1.01B |
| Q3 2022 | 213 | $901.8M |
| Q2 2022 | 219 | $1.17B |
| Q1 2022 | 236 | $1.49B |
| Q4 2021 | 218 | $1.23B |
| Q3 2021 | 208 | $1.18B |
| Q2 2021 | 184 | $939.5M |
| Q1 2021 | 177 | $842.1M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Innoviva, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atom Investors LP | 0 | $0 | 0.00% | −21,457−100.0% | Sold out |
| Integrated Quantitative Investments LLC | 0 | $0 | 0.00% | −20,881−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −20,497−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −19,498−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −18,358−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −17,898−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −14,980−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −11,339−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |
| OP Asset Management Ltd | 0 | $0 | 0.00% | −5,220−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −566−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −560−100.0% | Sold out |
| Private Wealth Asset Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −238−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Optima Capital LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Signature Resources Capital Management, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Brandywine Global Investment Management, LLC | – | – | – | – | Not filed |
| QSV Equity Investors LLC | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |